Sekar Kathiresan
Gründer bei VERVE THERAPEUTICS, INC.
Vermögen: 4 Mio $ am 30.04.2024
Aktive Positionen von Sekar Kathiresan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERVE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 01.07.2019 | - | |
Gründer | 01.01.2018 | - | |
RELAY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 25.07.2022 | - |
Independent Dir/Board Member | 25.07.2022 | - | |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.04.2022 | - |
Gründer | 01.04.2022 | - |
Karriereverlauf von Sekar Kathiresan
Ehemalige bekannte Positionen von Sekar Kathiresan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.07.1997 | 01.08.2021 |
Harvard Medical School | Corporate Officer/Principal | 01.06.2018 | 01.06.2021 |
Center for Genomic Medicine Massachusetts General Hospital | Direktor/Vorstandsmitglied | 01.04.2016 | 01.06.2019 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2014 | 01.06.2019 |
Ausbildung von Sekar Kathiresan
University of Pennsylvania | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Founder | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VERVE THERAPEUTICS, INC. | Health Technology |
RELAY THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Center for Genomic Medicine Massachusetts General Hospital | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Commercial Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
- Börse
- Insiders
- Sekar Kathiresan
- Erfahrung